Genomics of ASD: Pathways to Biological Convergence and Genetic Therapies RFA

Grants awarded through this RFA are intended to advance our understanding of the genetic basis of ASD and the molecular and cellular consequences of genetic risk, and to provide a foundation for the development of treatments for select genetically defined forms of the condition.

Focus Area 1: Integrative Analyses of Multi-omic ASD Data.

Focus Area 2: Functional Analysis of Associated Variants

Focus Area 3: Genetic Therapies

This RFA offers three funding tracks: 

1. Explorer track
    early-stage projects in which establishing feasibility and proof-of-concept are the most relevant outcomes of the grant period
   Funding: $400,000 total 
   Duration: 2 years 
    
2. Expansion track
   mature projects with evidence of feasibility and preliminary validity
   Funding: $1,500,000 total 
   Duration: 3 years 
    
3. Collaboration track
   multi-lab collaborative projects. Collaborative proposals should be built around transdisciplinary teams that link analyses across different levels of biological complexity 
   Funding: $750,000 total per participating lab
   Duration: 3 years 

Research Authority due date: 11.8.22